SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Psychemedics Corporation (PMD) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 21/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — PMD
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.80
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.32
Book Value / Share$0.00
Revenue / Share$3.36
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2015 |
$0.28 |
$26.98M |
$1.51M |
5.6% |
| 2016 |
$1.22 |
$38.98M |
$6.68M |
17.1% |
| 2017 |
$1.10 |
$39.7M |
$6.12M |
15.4% |
| 2018 |
$0.83 |
$42.67M |
$4.58M |
10.7% |
| 2019 |
$0.28 |
$37.68M |
$1.54M |
4.1% |
| 2020 |
$-0.70 |
$21.36M |
$-3.86M |
-18.1% |
| 2021 |
$-0.12 |
$24.91M |
$-665K |
-2.7% |
| 2022 |
$-0.19 |
$25.24M |
$-1.08M |
-4.3% |
| 2023 |
$-0.72 |
$22.1M |
$-4.15M |
-18.8% |
| 2024 |
$-0.32 |
$19.69M |
$-1.86M |
-9.5% |
